Introduction Lung cancer is rapidly increasing in morbidity and mortality, with a 5-year survival rate of 10–20% due to late-stage diagnosis and limited treatments. Around 85–90% of cases are non-small cell lung cancer (NSCLC), including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The International Association for Lung Cancer

Artificial intelligence is now moving from pilot projects to becoming a core layer of how hospitals operate. This episode will focus on how AI agents are being used to streamline clinical workflows, optimise hospital resources, and support safer, faster decision-making across healthcare systems. Date: 19th January 2026 Time: 9:00 PM IST | 11:30 AM

Introduction: Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by excessive platelet production, increasing the risk of thrombosis and hemorrhage (1). Current treatments aim to control platelet counts and reduce thrombotic events (1). LSD1 (lysine-specific demethylase 1) plays a role in hematopoietic cell differentiatio

Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. WHO Updates HIV Treatment and Prevention Guidance The World Health Organization has released updated HIV clinical guidelines, strengthening antiretroviral therapy recommendations, prevention of vertical transmission, and tuberculosis proph

Can doctors trust artificial intelligence? Join our upcoming webinar to explore how clinicians can shape, validate, and guide AI tools that are transforming modern medicine. Hear from: Mr. Bharat Gera — AI in Healthcare: The Human Voice — Expectations, Fears, and What Works Dr. Annie Hartley — Clinician-Led AI: How Doctors Should Validate and Trust

In this insightful KOL (Key Opinion Leader) interview, we speak with Dr. Shilpa Gandhi, an experienced Thoracic Surgeon from Nagpur, Maharashtra, India, to address a critical challenge in oncology care—lung cancer and the importance of early surgical referral. Dr. Gandhi emphasizes that timely referral to a thoracic surgeon is not just a procedural

Introduction: Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by sustained thrombocytosis and an elevated risk of thrombotic and hemorrhagic complications. Standard cytoreductive therapies- such as hydroxyurea, interferons, and anagrelide- are effective in many but are limited by resistance, intolerance, or sub

Introduction Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases (1). Prognosis is particularly poor in patients with advanced stage IV disease, especially when tumors lack actionable driver mutations such as epidermal growth factor recept

Introduction (1) Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and frequently presents at advanced stages with limited curative options. Patients with recurrent or stage IV non-squamous NSCLC expressing programmed death-ligand 1 (PD-L1) remain a population in need of improved first-line treatment strategies. Combination